Opko Health, Inc. - Common Stock (NQ:OPK)

1.570 +0.010 (+0.64%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Opko Health, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

OLB Group And 2 Other Stocks Under $1 Insiders Are Buying ↗

January 22, 2024

The Dow Jones index closed higher by around 400 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

What Vitamins Did For Healthy Living, Stemtech Corporation (OTCQB: STEK) Says It Is Doing For Anti-Aging With Stem Cell Nutrition ↗

January 19, 2024

Vitamins may not be a miracle cure, but combined with exercise and a healthy diet, they have the potential to greatly improve health and wellness. It’s no wonder vitamin supplements are a multi-billion...

Via Benzinga

Collective Audience And 3 Other Stocks Under $1 Insiders Are Buying ↗

January 18, 2024

The Dow Jones index closed lower by around 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

OPKO Health And 3 Other Stocks Under $2 Insiders Are Buying ↗

January 17, 2024

The Dow Jones index closed lower by over 200 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Why OPKO Health Stock Is Getting Hammered ↗

January 04, 2024

OPKO Health Inc (NASDAQ: OPK) shares are trading lower by 26.3% to $1.10 Thursday morning.

Via Benzinga

Earnings Scheduled For November 6, 2023 ↗

November 06, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.

Via Benzinga

Earnings Preview: OPKO Health ↗

November 03, 2023

Via Benzinga

Opko Health (OPK) Q2 2023 Earnings Call Transcript ↗

August 04, 2023

OPK earnings call for the period ending June 30, 2023.

Via The Motley Fool

Entera Bio And 3 Other Stocks Under $1 Insiders Are Buying ↗

January 12, 2024

The Dow Jones index closed slightly higher on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested...

Via Benzinga

Topics Stocks

Over $6M Bet On This Tech Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying ↗

January 11, 2024

The Dow Jones index closed higher by over 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

OPKO Health And 3 Other Stocks Under $5 Insiders Are Buying ↗

January 09, 2024

The Dow Jones index closed higher by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Crude Oil Moves Lower; Walgreens Posts Upbeat Earnings ↗

January 04, 2024

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining over 100 points on Thursday. The Dow traded up 0.33% to 37,554.56 while the NASDAQ fell 0.10% to 14,578.04. The S&P...

Via Benzinga

Topics Stocks

Earnings Scheduled For August 3, 2023 ↗

August 03, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.

Via Benzinga

A Preview Of OPKO Health's Earnings ↗

August 02, 2023

Via Benzinga

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 08, 2024

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...

Via Benzinga

Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 04, 2024

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 04, 2024

Via Benzinga

Dow Surges 200 Points; US Services PMI Edges Higher In December ↗

January 04, 2024

U.S. stocks traded mostly higher midway through trading, with the Dow Jones index gaining around 200 points on Thursday. The Dow traded up 0.55% to 37,635.05 while the NASDAQ rose 0.05% to 14,599.10....

Via Benzinga

Topics Stocks

Cal-Maine Posts Downbeat Q2 Results, Joins Dyne Therapeutics, OPKO Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

January 04, 2024

U.S. stock futures were higher this morning, with the Dow Jones futures gaining around 50 points on Thursday.

Via Benzinga

Topics Stocks

NextPlat latest financial numbers shows double-digit growth in e-commerce and healthcare division

November 15, 2023

Charlie Fernandez, CEO of NextPlat, provided an update on the company's latest financial results during an interview with Steve Darling from Proactive.

Via TheNewswire.com

Opko Health (OPK) Q3 2023 Earnings Call Transcript ↗

November 07, 2023

OPK earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

US Stocks Set To Extend 5-Day Winning Streak Today? Traders Anxiously Watch Fed Speech, Climbing Bond Yields ↗

November 06, 2023

The market looks set to extend last week’s gains, with the stock futures holding up early Monday ahead of a slew of earnings reports mostly from the small and mid-cap space.

Via Benzinga

Topics Economy

BioMedNewsBreaks – NextPlat Corp. (NASDAQ: NXPL) Announces Launch of OPKO Health Inc. (NASDAQ: OPK)-Branded Online Storefront

October 12, 2023

Via Investor Brand Network

NextPlat's Florida E-Commerce Development Program to Launch the Online Sales of OPKO Healthcare Products in China on Alibaba's Tmall Global

October 12, 2023

Via ACCESSWIRE

Why Glimpse Group Shares Are Trading Lower By Around 41%; Here Are 20 Stocks Moving Premarket ↗

September 29, 2023

Gainers RVL Pharmaceuticals plc (NASDAQ: RVLP) shares rose 181.8% to $0.2201 in pre-market trading.

Via Benzinga

Nike, OPKO Health And Other Big Stocks Moving Higher In Friday's Pre-Market Session ↗

September 29, 2023

U.S. stock futures traded higher this morning on Friday. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

MarketWise And 2 Other Stocks Under $2 Insiders Are Buying ↗

August 16, 2023

The Dow Jones closed lower by more than 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Paysafe, Taylor Devices, SomaLogic And Other Big Stocks Moving Higher On Tuesday ↗

August 15, 2023

U.S. stocks traded lower, with the Dow Jones falling around 300 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

August 04, 2023

Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.

Via Benzinga

Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday ↗

August 04, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.